What is Vertex Pharmaceuticals's u.s. tax on foreign earnings, net of credits?

Vertex Pharmaceuticals (VRTX) reported u.s. tax on foreign earnings, net of credits of -12.6% in Q4 2024.

What does u.s. tax on foreign earnings, net of credits mean?

The net tax cost or benefit of taxing foreign earnings in the U.S. after accounting for credits.

U.S. tax on foreign earnings, net of credits

Vertex Pharmaceuticals U.S. tax on foreign earnings, net of credits decreased by 1900.0% to -12.6% in Q4 2024 compared to the prior quarter. This is a positive signal — lower values indicate better performance for this metric.

Analysis

StatementIncome Statement

SectionOther

CategoryEfficiency

SignalLower is better

VolatilityModerate

First reportedQ4 2023

Last reportedQ4 2024Feb 13, 2026

How to read this metric

Lower costs indicate more efficient management of foreign earnings and tax credit utilization.

Detailed definition

This metric measures the U.S. tax impact on foreign earnings, net of applicable foreign tax credits. It reflects the tax...

Peer comparison

Standard metric for U.S.-based multinationals to reconcile global tax burdens.

Metric ID: other_effective_income_tax_rate_reconciliation_repatriat_10b517

Historical Data

2 periods

	Q4 '23	Q4 '24
Value	0.7%	-12.6%
QoQ Change	—	<-999%
YoY Change	—	<-999%

Range-12.6% – 0.7%

Avg YoY Growth<-999%

Median YoY Growth<-999%

U.S. tax on foreign earnings, net of credits at Other Companies

Ford Motor CompanyF View metric

General MillsGIS View metric

GE VernovaGEV View metric

PPG IndustriesPPG View metric

The Kraft Heinz CompanyKHC View metric

GE VernovaGEV View metric

Frequently Asked Questions

What is Vertex Pharmaceuticals's u.s. tax on foreign earnings, net of credits?: Vertex Pharmaceuticals (VRTX) reported u.s. tax on foreign earnings, net of credits of -12.6% in Q4 2024.
What does u.s. tax on foreign earnings, net of credits mean?: The net tax cost or benefit of taxing foreign earnings in the U.S. after accounting for credits.